Tower Research Capital (TRC)’s ZyVersa Therapeutics ZVSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.06K Buy
4,525
+2,370
+110% +$1.61K ﹤0.01% 4556
2025
Q1
$1.36K Sell
2,155
-1,328
-38% -$835 ﹤0.01% 4728
2024
Q4
$3.69K Buy
3,483
+917
+36% +$972 ﹤0.01% 4614
2024
Q3
$6.16K Buy
2,566
+1,867
+267% +$4.48K ﹤0.01% 4174
2024
Q2
$2.63K Sell
699
-155
-18% -$583 ﹤0.01% 4981
2024
Q1
$6.41K Buy
854
+456
+115% +$3.42K ﹤0.01% 4376
2023
Q4
$3.58K Buy
398
+382
+2,388% +$3.44K ﹤0.01% 5058
2023
Q3
$750 Hold
16
﹤0.01% 5482
2023
Q2
$1.41K Buy
16
+3
+23% +$265 ﹤0.01% 5356
2023
Q1
$9K Buy
+13
New +$9K ﹤0.01% 4554